Working... Menu

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00146276
Recruitment Status : Unknown
Verified September 2005 by Association of Urologic Oncology (AUO).
Recruitment status was:  Recruiting
First Posted : September 7, 2005
Last Update Posted : September 27, 2006
Eli Lilly and Company
Information provided by:
Association of Urologic Oncology (AUO)

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given